193 related articles for article (PubMed ID: 31143933)
1. Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei.
Yu Y; Williams A; Zhang X; Fu L; Xia K; Xu Y; Zhang F; Liu J; Koffas M; Linhardt RJ
Glycobiology; 2019 Jul; 29(8):572-581. PubMed ID: 31143933
[TBL] [Abstract][Full Text] [Related]
2. Deciphering mode of action of heparanase using structurally defined oligosaccharides.
Peterson S; Liu J
J Biol Chem; 2012 Oct; 287(41):34836-43. PubMed ID: 22893710
[TBL] [Abstract][Full Text] [Related]
3. Molecular Aspects of Heparanase Interaction with Heparan Sulfate, Heparin and Glycol Split Heparin.
Elli S; Guerrini M
Adv Exp Med Biol; 2020; 1221():169-188. PubMed ID: 32274710
[TBL] [Abstract][Full Text] [Related]
4. Design of an Ultralow Molecular Weight Heparin That Resists Heparanase Biodegradation.
Ham H; Xu Y; Haller CA; Dai E; Stancanelli E; Liu J; Chaikof EL
J Med Chem; 2023 Feb; 66(3):2194-2203. PubMed ID: 36706244
[TBL] [Abstract][Full Text] [Related]
5. Multi-faceted substrate specificity of heparanase.
Peterson SB; Liu J
Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
[TBL] [Abstract][Full Text] [Related]
6. Heparanase - Discovery and Targets.
Lindahl U; Li JP
Adv Exp Med Biol; 2020; 1221():61-69. PubMed ID: 32274706
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the specificity of heparanase utilizing synthetic substrates.
Peterson SB; Liu J
J Biol Chem; 2010 May; 285(19):14504-13. PubMed ID: 20181948
[TBL] [Abstract][Full Text] [Related]
8. Structural recognition by recombinant human heparanase that plays critical roles in tumor metastasis. Hierarchical sulfate groups with different effects and the essential target disulfated trisaccharide sequence.
Okada Y; Yamada S; Toyoshima M; Dong J; Nakajima M; Sugahara K
J Biol Chem; 2002 Nov; 277(45):42488-95. PubMed ID: 12213822
[TBL] [Abstract][Full Text] [Related]
9. Functional and structural characterization of a heparanase.
Bohlmann L; Tredwell GD; Yu X; Chang CW; Haselhorst T; Winger M; Dyason JC; Thomson RJ; Tiralongo J; Beacham IR; Blanchard H; von Itzstein M
Nat Chem Biol; 2015 Dec; 11(12):955-7. PubMed ID: 26565989
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
[TBL] [Abstract][Full Text] [Related]
11. Heparosan Chain Characterization: Sequential Depolymerization of E. Coli K5 Heparosan by a Bacterial Eliminase Heparin Lyase III and a Bacterial Hydrolase Heparanase Bp to Prepare Defined Oligomers.
Datta P; Yan L; Awofiranye A; Dordick JS; Linhardt RJ
Biotechnol J; 2021 Mar; 16(3):e2000336. PubMed ID: 33006278
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
[TBL] [Abstract][Full Text] [Related]
13. Chemically modified heparins as inhibitors of heparan sulfate specific endo-beta-glucuronidase (heparanase) of metastatic melanoma cells.
Irimura T; Nakajima M; Nicolson GL
Biochemistry; 1986 Sep; 25(18):5322-8. PubMed ID: 3768351
[TBL] [Abstract][Full Text] [Related]
14. Computational analyses of the catalytic and heparin-binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-β-D-glucuronidase (heparanase).
Gandhi NS; Freeman C; Parish CR; Mancera RL
Glycobiology; 2012 Jan; 22(1):35-55. PubMed ID: 21746763
[TBL] [Abstract][Full Text] [Related]
15. Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
Casu B; Naggi A; Torri G
Matrix Biol; 2010 Jul; 29(6):442-52. PubMed ID: 20416374
[TBL] [Abstract][Full Text] [Related]
16. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.
Mao Y; Huang Y; Buczek-Thomas JA; Ethen CM; Nugent MA; Wu ZL; Zaia J
J Biol Chem; 2014 Dec; 289(49):34141-51. PubMed ID: 25336655
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity of heparanases from human hepatoma and platelets.
Pikas DS; Li JP; Vlodavsky I; Lindahl U
J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
[TBL] [Abstract][Full Text] [Related]
19. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
Marchetti D; Liu S; Spohn WC; Carson DD
J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.
Bar-Ner M; Eldor A; Wasserman L; Matzner Y; Cohen IR; Fuks Z; Vlodavsky I
Blood; 1987 Aug; 70(2):551-7. PubMed ID: 2955820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
